A STAT1 Phe172Leu gain-of-function mutation is associated with low T regulatory cells.
Proliferation of T cells in response to anti-CD3 and IL-2 was unaltered.
The index patient presents with signs of common variable immunodeficiency (CVID).
The mutation carrier suffers from dystrophy and delayed neurocognitive development.